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Transplantation of various numbers of foreign bone-marrow 
cells in mice after lethal and supralethal X-irradiationf 
0. Vos 
Medical Biological Laboratory RVO-TNO, 139 Lange Kleiweg, 
Rijswijk, The Netherlands 
{Received 2 March 1964) 
Survival of irradiated mice treated with sub-optimal numbers of allogeneic 
bone-marrow cells could not be improved by addition of a large number of 
bone-marrow cells derived from the same donor strain and made incapable of 
proliferation by irradiation with 3000 r. This argues against the absorption 
of ' natural antibodies ' by excess of antigen. 
Survival-curves of mice treated with sub-optimal numbers of allogeneic 
bone-marrow cells showed the greatest mortality in the period of 10-20 days 
after lethal irradiation. This mortality was diminished if the hosts were 
irradiated with supralethal x-ray doses. In the combinations studied the 
number of required allogeneic or rat marrow cells was decreased after supra-
lethal irradiation of the recipients. 
Determinations of the number of nucleated cells present in bone-marrow 
and spleen showed a continuous increase in lethally-irradiated mice treated 
with syngeneic cells and in supralethally-irradiated mice treated with 
allogeneic cells. In lethally-irradiated mice treated with allogeneic bone-
marrow cells, this increase was interrupted at about 14 days after irradiation 
by a small transitory remission. 
These data were explained on the basis of an active immunological response 
after an extended induction period in lethally-irradiated mice treated with 
foreign cells. After supralethal irradiation this residual response is depressed. 
Stimulation of the phagocytic activity of the RES through zymosan 
injections did not decrease survival of lethally- and supralethally-irradiated 
mice that were treated with allogeneic or rat bone-marrow suspensions. 
Instead there was a tendency toward a beneficial effect on survival. 
1. INTRODUCTION 
Soon after the discovery that the therapeutic effect of inoculated haematopoietic 
tissue in lethally-irradiated mice is based on transplantation of proliferating cells, 
the number of cells required for an effective treatment was studied. I t was 
ascertained that more allogeneic and rat cells than isogeneic cells were needed 
for a successful treatment (Van Bekkum and Vos 1957). In isogeneic bone-
marrow suspensions, the number of stem-cells capable of proliferation determine 
repopulation and therapeutic results (McCulloch and Till 1960, Till and 
f This investigation was supported by Euratom (European Atomic Energy Community), 
51-53 Rue Belliard, Brussels, Belgium. 
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McCulloch 1961), but in allogeneic combinations other factors are involved 
(McCulloch and Till 1963). The difference in number of required syngeneic 
and foreign cells, is generally thought to be due to an immunological reaction 
of the host versus the graft (Van Bekkum and Vos 1957), but no precise description 
of the character of this reaction has been given. 
Vos, Crouch and Van Bekkum (1961) observed that a delayed foreign bone­
marrow injection gave, in some respects, ameliorated transplantation results. 
This effect was ascribed to a lesser degree of the host­versus­graft reaction at 
that time. The influence of a delayed transplantation on the required number 
of allogeneic and rat bone­marrow cells, however, was very small and observed 
in the C57BL­>CBA combination only. 
In the present paper some factors which might influence the number of 
foreign bone­marrow cells required in a given combination were studied. 
Firstly the nature and degree of an immunological graft­versus­host reaction 
after lethal and supralethal radiation doses were investigated. A differentiation 
was made between : 
(a) the possible occurrence of cytotoxic reactions due to natural antibodies 
against allogeneic transplantation antigens, and 
(b) the presence of a residual induced immunological response after lethal 
x­ray doses. 
In the second place the influence of the RES was considered. Wooles and 
Di Luzio (1962) activated the RES by zymosan injections and described a higher 
death­rate and shorter survival­time of these mice after lethal x­irradiation 
and foreign bone­marrow transplantation. For this reason the influence of 
the activity of the RES on the number of required allogeneic and rat bone­
marrow cells for treatment after lethal and supralethal irradiation was tested 
in our experiments. 
2. METHODS 
Male mice of the inbred strains (C57BL/Rij and CBA/Rij and their Fx 
hybrids 8­13 weeks old and weighing 20­30 g were used as recipients. Donor 
bone­marrow suspensions were prepared from young adult CBA/Rij, 
(RF χ C57BL/Rij)F1 mice and from young rats. A few hours before bone­
marrow transplantation recipients were exposed to a lethal dose of whole­body 
x­irradiation. Radiation constants were: 200kv (constant potential); 18mA; 
filtration 1­5 mm Cu; h.v.l. 1­8 mm Cu; distance to target 50 cm; dose­rate 
46r/min. During exposure, 10­16 mice were placed in a circular perspex 
container. Maximal backscatter was achieved by placing the container on a 
layer of 11cm hard­board. Irradiation of bone­marrow suspensions in vitro 
was performed in the manner described previously by Smith and Vos (1962). 
Preparation of bone­marrow and spleen suspensions was described by Vós 
and Weyzen (1962). Suspensions were injected into the tail­vein without 
anaesthesia within a few hours after irradiation. In one experiment mentioned 
in the text this period was 24 hours. 
Numbers of nucleated cells present in bone­marrow and spleen were estimated 
by preparing cell­suspensions from two femurs or from the spleen and by count­
ing the number of cells in a haemocytometer. 
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Zymosan (obtained from Standard Brands Inc., New York, N.Y., U.S.A.) 
suspensions were homogenized in distilled water in a Potter Elvehjem apparatus 
and heated in a boiling­water bath for 30 min. Hyperfunction of the RES 
was obtained by intravenous and/or intraperitoneal injections as specified in 
each experiment (see §3.3). The phagocytic activity of the RES was evaluated 
by determining the removal rate of intravascular colloidal carbon at different 
times after zymosan injections. An amount of 8 mg carbon (preparation 
C ll/1431a Günther Wagner, Hanover, Germany) was injected per mouse. 
3. RESULTS AND DISCUSSION 
3.1. Natural antibodies 
Cytotoxic substances against foreign cells are common in many xenogeneic 
combinations and, although the occurrence of such ' natural antibodies ' has 
not been established in allogeneic combinations, very slight reactions are difficult 
to rule out. If minimal numbers of haematopoietic cells are injected into 
Number of 
injected 
bone­marrow 
cells (millions) 
0 
0­2 
0­4 
0­8 
3­2 
Addition of irradiated 
bone­marrow cellsf 
+ 
15­ 0 
20­10­ 2 
10­ 5 ­ 3 
20­17­14 
10­10­10 
­
10­ 0 
20­11­ 3 
10­ 8­ 4 
20­20­14 
10­10­10 
f Bone­marrow cells were irradiated with 3000 r. The figures express number of 
surviving mice at days 0, 15 and 30 after irradiation. 
Table 1. Influence of addition of lethally­irradiated CBA bone­marrow cells on number 
of non­irradiated CBA cells required for allogeneic bone­marrow treatment. 
Recipients were C57BL mice irradiated with 915 r. 
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Figure 1. Survival of C57BL/Rij mice treated with various doses of CBA/Rij bone­
marrow cells. X­ray dose 800 r. Figures between brackets indicate number of 
mice per group. 
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allogeneic hosts, a small number of cells is exposed to the whole pool of these 
antibodies, and this might influence the take of the grafted cells. This possibility 
was tested by addition of a large number of bone-marrow cells, made incapable 
of proliferation by irradiation with 3000 r, to small numbers of non-irradiated 
cells derived from the same donors. Survival of lethally-irradiated mice treated 
with these cell-suspensions was compared with survival of mice treated with 
the same numbers of non-irradiated cells only. The results depicted in table 1 
revealed no difference in survival between both groups of mice and thus do not 
argue in favour of the presence of naturally-occurring cytotoxic antibodies, 
which can be absorbed by injected allogeneic cells. 
The shape of the cumulative mortality-curves of lethally-irradiated mice 
treated with small numbers of allogeneic cells (figure 1) provides another 
argument against the occurrence of such natural antibodies. If the mortality 
were due to natural antibodies, this would lead to the survival of an insufficient 
number of allogeneic cells, resulting in either a survival-curve of the type expected 
for the untreated irradiated controls or in survival beyond the 30th day when 
secondary disease first appears. Similar results are found when small numbers 
of syngeneic cells are transplanted. In the present investigation, however, 
the survival-time of many mice has been prolonged beyond that of controls, 
and little or no survival is observed at 30 days after irradiation. This suggests 
that the cells are not killed shortly after injection, but proliferate to some extent. 
The production of new peripheral cells after 10-14 days, however, is insufficient 
to keep the mice alive much longer. 
3.2. Adire immunological response 
A single whole-body irradiation provokes a considerable decrease in the 
capacity for a primary immunological response. Results with mice exposed 
to an LD25_:!() have been described by Gengozian and Makinodan (1958). How-
ever, the immunological response of mice irradiated with a median lethal x-ray 
dose is still sufficient to reject allogeneic or rat bone-marrow transplants in 
some host-donor combinations (Van Bekkum and Vos 1957, Congdon, 
Makinodan and Gengozian 1957, Uphoff 1963). 
After lethal radiation doses, allogeneic bone-marrow cells are generally 
accepted, able to proliferate and capable of producing a functional haema-
topoietic system, but 'reversals'—mice in which host cells take over the 
function of donor cells—occur (Welling, Vos, Weyzen and Van Bekkum 1959). 
This might indicate that a delayed immunological reaction of the recipient's 
immunological system is still present after whole-body irradiation with an LD100. 
No reversals are found if the irradiation is markedly higher than the minimal 
LD100 (to be called 'supralethal irradiation ') . The existence of a residual and 
late immunological response after lethal x-ray doses is hard to demonstrate with 
the usual immunological techniques, because animals die within 10-14 days 
after irradiation. The survival-curves of irradiated mice treated with minimal 
numbers of bone-marrow cells and the proliferation data of injected bone-
marrow cells in our experiments provide arguments for a small immunological 
reaction after a lethal whole-body irradiation. This reaction is probably an 
important factor in determining the minimal number of foreign bone-marrow 
cells required. 
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3.2.1. Survival of mice 
Survival-curves of mice subjected to a supralethal x-ray dose and treated 
with minimal numbers of bone-marrow cells are displayed in figure 2. Survival 
at 30 days after irradiation appears to increase with increasing number of injected 
bone-marrow cells. The most obvious differences with similar data obtained 
after a lethal (LD100) irradiation (figure 1) are that (1) 30-day survival of 
supralethally-irradiated mice is higher in every group of mice treated with the 
same number of bone-marrow cells and (2) the most striking difference in death 
pattern of mice treated with the same dose of bone-marrow cells, but subjected 
to different x-ray doses, is found in the period of 10-20 days after irradiation. 
This last observation is further illustrated in table 2. These data suggest an 
IUU— 
80-
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percentage 
mortality 
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20 
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0β«»6(50) 
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30 
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Figure 2. Survival of C57BL/Rij mice treated with various doses of CBA/Rij bone-
marrow cells. X-ray dose 915 r. Figures between brackets indicate number of 
X-ray dose 
(r) 
800 
915 
Number of mice 
176 
230 
Percentage deaths in periods 
0-10 days 
14 
15 
10-20 days 
71 
40 
20-30 days 
7 
13 
Table 2. Death pattern of C57BL mice treated with 0-1-0-8 million CBA bone-marrow 
cells. Results from experiments represented in figures 1, 2 and 3 (a). 
insufficient proliferation of small numbers of grafted bone-marrow cells to sustain 
life in the period between 10-20 days after a lethal irradiation. Comparison 
of survival at 30 days after 770 or 800 r and 915 r in some allogeneic and xenogeneic 
combinations is given in figure 3. In every combination smaller numbers of 
bone-marrow cells are required at the highest radiation dose. The effect is 
also present if transplantation was delayed for 24 hours after irradiation (figure 
3 (a)). Data not represented in the graphs indicated that a 24-hour delay 
caused no further significant increase of survival of supralethally-irradiated 
mice. Some experiments performed with mice irradiated with 1030 r demon­
strated that an even more effective treatment of the bone-marrow syndrome 
* * 
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with small doses of allogeneic bone-marrow cells could be obtained than after 
irradiation with 915 r. These results, however, were obscured by an early death 
pattern, probably due to the intestinal syndrome. 
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Figure 3. Survival of lethally- and supralethally-irradiated mice after allogeneic and rat 
bone-marrow treatment. 
A: CBA/Rij-> C57BL/Rij ; 
Β : rat - ν (CBA/Rij χ C57BL/Rij)F1; 
C: C57BL/Rij-> CBA/Rij. 
In experiments of A and Β bone-marrow was injected within a few hours after 
irradiation, in experiments of C, 24 hours after irradiation. Figures indicate number 
of mice per point. 
3.2.2. Proliferation of haematopoietic cells 
Since the survival data of recipient mice suggested an insufficient proliferation 
of small numbers of grafted foreign bone-marrow cells between 10 and 20 days 
after irradiation with an LD100, repopulation of spleen and bone-marrow was 
studied at various times after transplantation. After transplantation of a small 
number of syngeneic cells in mice irradiated with a lethal or a supralethal dose, 
a continuous increase of the number of nucleated cells was found (figure 4) 
in the spleen starting between 4 and 7 days and in the bone-marrow between 
7 and 11 days after transplantation. In the spleen an overshoot was observed 
around the 14th day. In the allogeneic combination C57BL/Rij->CBA/Rij, 
the repopulation of spleen and bone-marrow was investigated after transplantation 
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of 0-1, 0-4 or 10 million bone-marrow cells in mice irradiated with 770 r 
(LD100) or with 1030 r (figure 5). The results exhibit a principal difference in 
repopulation of mice irradiated with different doses. This difference was most 
evident 14 days after irradiation. Comparison of mice treated with the same 
number of cells but irradiated with different x-ray doses revealed that 14 days 
after treatment a greater number of nucleated cells was found in mice irradiated 
with 1030 r than in those irradiated with 770 r. This difference was significant 
for mice inoculated with 0-4 χ IO6 and 10 χ IO6 cells, but not significant for 
the groups treated with 0-1 χ IO6 bone-marrow cells. Repopulation of bone 
marrow and spleen started simultaneously after both radiation doses. At 10 
number of 
nucleated cells ( x lo 6 ) 
number of 
nucleated cells (x IO6) 
spleen 
11 14 21 47 
days after irradiation 
—Hi Γ -
21 47 
days after irradiation 
Figure 4. Repopulation of bone-marrow and spleen in lethally- and supralethally-
irradiated (CBA/Rij χ C57BL/Rij)F! mice treated with 0-1 χ IO6 isogeneic bone-
marrow cells, β non-irradiated controls, · · lethally-irradiated mice (800 r), 
O O supralethally-irradiated mice (1030 r). To facilitate drawing, this curve 
has been shifted a little to the right. The points indicate the mean value of groups 
of six mice, with standard variations. 
days and later this repopulation continued in mice irradiated with 1030 r, whereas 
a decrease in number of nucleated cells was found in mice irradiated with 770 r. 
This drop was not significant in the single curves, but a significance could be 
demonstrated if the data of all curves were combined. Statistical methods 
applied were derived from Wilcoxon (1945) and Fisher (1948). These data 
confirm and extend earlier conclusions (De Vries and Vos 1959) inferred from 
pathological observations. In the last paper it was considered likely that 
mortality in the second half of the first month after treatment with allogeneic 
or xenogeneic bone-marrow was due either to the failure of the graft to take 
or to its secondary rejection. Our present data are in favour of the latter 
possibility. 
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3.3. Phagocytic activity of the RES 
The influence of an activation of the phagocytic capacity of the reticulo­
endothelial systern by zymosan injections on transplantability of minimal numbers 
of foreign bone-marrow cells was studied in the combinations 
(RF χ C57BL/Rij)F1-> (CBA/Rij χ C57BL/Rij)F1 
and rat-> (CBA/Rij χ C57BL/Rij)F1. 
A survey of the schemes for the treatment and the results of the stimulation 
number of cells (x 10° number of cells (xlO^) 
3 0 0 - , 
I I — Ι Γ 
0 2 4 7 10 14 
days after irradiation days after irradiation 
Figure 5. Repopulation of bone-marrow and spleen in lethally- and supralethally-
irradiated CBA/Rij mice treated with 0 1 χ IO6 (A and B), 0-4x10" (C and D) 
and 10 χ 10" (E and F) C57BL/Rij bone-marrow cells. Symbols as given in figure 
4. Where figures are given they relate to mice numbers, other than six, used to 
establish the related point. 
Experiment 
1 A 
Β 
2 
3 
4 
5 
6 
Controls 
Treatmentf 
0-6 mg i.p. days 9, 8 and 7 
0-6 mg i.p. day 8 
0-6 mg i.p. days 4, 3 and 2 
0-5 mg i.p. days 4, 3 and 2 
0-5 mg i.p. days 4, 3 and 2 
0-7 mg i.p. days 4, 3, 2 and 1 
0-7 mg i.v. days 4, 3, 2 and 1 
0-7 mg i.p. days 11, 10 ,9 ,8 ,7 , 3, 2 and 1 
0-7 mg i.v. days 10, 8, 4 and 2 
5 mg i.p. days 4, 3, 2 and 1 
— 
Days after 
last injection 
on which 
determinations 
were 
performed 
2, 5 and 8 
3, 6 and 9 
2, 6 and 9 
2, 5 and 9 
1 ,4 ,6 ,8 , 12 and 14 
1,4, 7 and 11 
1,4, 7 and 12 
— 
Mean valuesj 
Total 
number 
of 
mice 
6 
6 
9 
6 
12 
15 
10 
20 
Weight 
spleen 
116 
101 
122 
160 
164 
155 
187 
92 
Carbon 
removal 
rate 
r,,2(min) 
16 
22 
15 
9 
8 
10 
14 
35 
t Milligrams zymosan on days before irradiation, exps. 1-5 lot No. OB298, exp. 6 lot No. 5B171. 
I Spleen-weight and carbon-removal rate in all experiments differ significantly from controls, except spleen-weight 
of experiment IB. 
Table 3. Zymosan treatment in different experiments and effects on RES. 
? 
&V 
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a a 
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is given in table 3. Stimulation of the RES is indicated by an increase in spleen 
weight and an increased carbon-removal rate, expressed as the time required 
fo_ the carbon concentration in the blood to drop to half its original value. The 
100η percentage survival 
at 30 days 
number of bone-mar row cells injected (x10 ) 
Figure 6. Effect of zymosan pretreatment on survival of (CBA/Rij χ C57BL/Rij)F] mice 
treated with (RF χ C57BL/Rij)F, bone marrow, x-ray dose 915 r. For details of 
zymosan pretreatment, see table 3, exps. 1 and 2 . · · control mice, 
O O zymosan-pretreated mice. Figures indicate the number of mice 'per 
point. 
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Figure 7. Effect of zymosan pretreatment on survival of (CBA/Rij χ C57BL/Rij)F1 mice 
treated with rat bone-marrow cells. X-ray dose 915 r (A) and 800 r (B). For 
details of zymosan pretreatment see table 3, exps. 3-6. Symbols as in figure 6. 
phagocytic activity in our normal mice, as well as the degree of activation by 
zymosan treatment, was much lower than in Wooles and Di Luzio's (1962) 
experiments, although a considerable activation could be reached. No significant 
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difference in 30-day survival between zymosan-pretreated and untreated controls 
was observed in any of the individual experiments either after irradiation with a 
LD100 or after irradiation with a supralethal x-ray dose. The combined results 
of the experiments represented in figures 6 and 7 indicate a tendency towards 
a higher 30-day survival of the zymosan-pretreated mice, particularly in those 
groups which were treated with suboptimal numbers of bone-marrow cells. 
4. CONCLUSIONS 
Attempts to absorb cytotoxic substances in allogeneic recipients by injection 
of a large number of bone-marrow cells made incapable of proliferation failed 
to improve survival of lethally-irradiated mice treated with suboptimal numbers 
of cells from the same donor strain. These data together with the survival-
curves of mice treated with suboptimal numbers of allogeneic cells suggested 
that small numbers of grafted cells were primarily accepted and that they provided 
an insufficient production of blood cells at a later time. 
The repopulation data of bone-marrow and spleen indicate that this insufficient 
production of blood cells is in part due to a too-slow regeneration process after 
inoculation of too small a number of stem cells and partly to a decrease in repopu-
lation around the 14th day. After injection of a large number of cells this 
decrease is also found, but it does not necessarily cause death of the host because 
of a much higher level of repopulation, which has already been established at 
that time. The best explanation for a decrease of the number of nucleated 
spleen and bone-marrow cells at about two weeks after transplantation seems 
to be an active immunological reaction of the host, which still occurs after lethal 
whole-body irradiation. The data obtained with supralethally-irradiated mice 
indicate that this residual immunological reaction can be further impaired by 
supralethal radiation doses. Final proof that this immunological reaction really 
exists will have to await the demonstration of the specific humoral or cellular 
bound antibodies. 
From the results it is evident that some decrease in the number of allogeneic 
cells required can be obtained by increasing the radiation dose above the LD1 0 0 
level. However, it was impossible to decrease this number of cells down to 
the level required for syngeneic cells. Difficulties due to the occurrence of 
an intestinal syndrome prevented an assessment of whether this could have 
been achieved after irradiation with still higher x-ray doses. 
We could not confirm the results of Wooles and Di Luzio (1962), who showed 
that a stimulated phagocytic activity of the reticulo-endothelial system counter-
acts foreign bone-marrow transplantation. The degree of activation reached in 
our experiments was much lower than in the experiments described by the 
former authors, but our use of suboptimal numbers of injected cells provided 
us with a much more sensitive test for rejection. The differences in survival 
between zymosan-pretreated mice and their controls indicate, if anything, that 
pretreatment with zymosan has a slight beneficial effect on survival. 
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32 O. Vos 
Il était impossible d'augmenter la survie de souris irradiées et traitées de quantités 
sous­optimales de moelle osseuse allogénique par l'addition d'un grand nombre de cellules 
de moelle osseuse de la même souche de souris et rendues incapable à proliférer après 
3000 r d'irradiation. L'absorption des anticorps naturels hypothétiques à la suite d'un 
excès d'antigènes est ainsi rendue improbable. Des courbes de survie des souris traitées 
de quantités sous­optimales de moelle osseuse allogénique montraient que la mortalité 
était la plus élevée pendant la période entre 10 à 20 jours après l'irradiation léthale. Cette 
mortalité était réduite si l'hôte fut irradié de doses de rayons­x supraléthales. Pour les 
combinaisons des souches étudiées ici, il fut trouvé que la quantité de moelle osseuse 
allogénique ou xénogénique (des rats) nécessaire pour survie, était moins si l'irradiation 
des receveurs était supraléthale. 
La détermination du nombre de cellules nuclées se trouvant dans la moelle osseuse et 
dans la rate des receveurs montrait une montée graduelle pour les souris léthalement 
irradiées et traitées de cellules syngéniques et également en cas des souris irradiées avec 
une dose supraléthale et traitées de cellules allogéniques. Chez les souris léthalement 
irradiées et traitées de cellules allogéniques cette augmentation du nombre des cellules de 
la moelle montrait une rémission environ quinze jours après l'irradiation. 
Ces résultats furent interprétés par la supposition d'une réponse immunologique par 
cettes souris léthalement irradiées et traitées de cellules allogéniques et xenogéniques soit 
après une longue période d'induction. Après une irradiation supraléthale une telle response 
immunologique était évidemment absente. 
Une stimulation de l'activité phagocytaire du R.E.S. par des injections de zymosan 
ne diminuait pas la survie des souris irradiées et traitées de la moelle osseuse. Au contraire, 
une telle stimulation avait peut­être même un effet bénéficiaire. 
Das Überleben bestrahlter Mäuse nach Behandlung mit suboptimalen Mengen 
homologer Konchenmarkzellen konnte nicht verbessert werden durch Hinzufügung 
einer großen Zahl von Knochenmarkzellen des gleichen Donorstammes die durch 
Bestrahlung mit 3000 r zum proliferieren unfähig gemacht waren. Diese Befunde sind 
unvereinbar mit einer möglichen Absorption hypothetischer natürlicher Antikörper infolge 
eines Übermaßes des betreffenden Antigens. 
Die Überlebenskurven von Mäusen, welche mit suboptimalen Mengen homologer 
Knochenmarkzellen behandelt wurden, zeigten die höchste Sterblichkeit in einer Periode 
von 10 bis 20 Tagen nach der Bestrahlung. Diese Mortalität war geringer, wenn der 
Empfänger mit einer supralethalen Dosis von X­Strahlen bestrahlt wurde. In den 
untersuchten Stammkombinationen hat sich herausgestellt, daß die Anzahl der benötigten 
homologen oder heterologen (Ratte) Knochenmarkzellen nach supralethaler Bestrahlung 
der Empfänger abnimmt. Bestimmungen der Anzahl von kernhaltigen Zellen im 
Knochenmark und in der Milz der Empfänger zeigten eine allmähliche Zunahme im Falle 
lethalbestrahlter isolog behandelter Mäuse und auch in supralethalbestrahlten Mäusen 
welche mit homologen Zellen behandelt waren. Jedoch bei den lethalbestrahlten Mäusen 
behandelt mit homologen Knochenmarkzellen, wurde diese Zunahme der Zellularität etwa 
14 Tage nach der Bestrahlung durch einen geringen vorübergehenden Rückgang 
unterbrochen. Diese Ergebnisse können durch Annahme einer immunologischen Reaktion 
erklärt werden, die nach einer längeren Induktionsperiode bei homolog oder heterolog 
behandelten Mäusen trotz lethaler Bestrahlung auftreten kann. Nach supralethaler 
Bestrahlung hingegen ist diese Restreaktion scheinbar unterdrückt. 
Stimulierung der phagozytären Aktivität der R.E.S. durch Zymosaninjektionen konnte 
das Überleben der lethal­ oder supralethalbestrahlten mit fremden Knochenmark behan­
delten Mäuse nicht vermindern. Stattdessen wurde eher eine Tendenz zu einem günstigen 
Einfluß auf das Überleben gefunden. 
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